Document is current
Any future updates will be listed below
-
Authors
Mao, Xiaoxie
Wang, Yan
Luan, Ying
Wang, Ying
Wang, Jie
Dai, Wenlin
Guan, Yihui
Huang, Qi
Gunn, Roger N.
Ossenkoppele, Rik
Li, Binyin
Li, Zijing
Guo, Qihao
Xie, Fang https://orcid.org/0000-0003-2667-281X
,
-
Funding
Funding for this research was provided by:
STI2030-Major Projects (2022ZD0213800)
the National Science Foundation of China (81801752, 82171473, 82201583, and 82071962)
the startup fund of Huashan Hospital, Fudan University (2017QD081)
- License Information
-
More Information
Article History
Received: 26 January 2025
Accepted: 3 October 2025
First Online: 29 October 2025
Declarations
:
: The study protocol adhered to ethical guidelines and was approved by the Institutional Review Boards of Huashan Hospital, Fudan University, and Ruijin Hospital. Written informed consent was obtained from all participants prior to their enrollment.
: R.O. has received research funding/support from Avid Radiopharmaceuticals, Janssen Research & Development, Roche, Quanterix and Optina Diagnostics, has given lectures in symposia sponsored by GE Healthcare, is an advisory board member for Asceneuron and a steering committee member for Biogen and Bristol Myers Squibb. All the aforementioned has been paid to these institutions. The authors report no disclosures relevant to the manuscript.
